Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 October 2024 | Story Litha Banjatwa | Photo Supplied
Matriculant of the year 2024
This year’s winner, Jayden Leech (centre), deputy head boy and hockey captain at Grey College.

For more than four decades, the University of the Free State (UFS) has used its annual Matriculant of the Year competition to attract the country’s top matriculants. This prestigious award recognises and celebrates the exceptional achievements of South African high school students who excel in academics, sports, culture, and leadership.

This year’s winner, Jayden Leech, deputy head boy and hockey captain at Grey College, stands out not only for his academic average of 90% but also for his sporting achievements. He has represented South Africa in karate and has been a member of the Free State Hockey and Waterpolo teams for the past three years. Jayden has been selected to pursue a medical degree.

The competition is closely aligned with the UFS’s Vision 130, which envisions a future where academic excellence, innovation, and societal impact are prioritised. “By recognising academic success, creativity, resilience, and leadership potential, the university aims to attract the brightest minds to join its community. This competition serves as a platform to identify and nurture future leaders who will help address South Africa's pressing challenges,” says Nomonde Mbadi, Director of Student Recruitment Services.

This year, the competition attracted 60 applicants, with a strong representation of women - 43 women and 17 men. The Free State province led with 28 entries, followed by North West, KwaZulu-Natal, and Gauteng. Popular fields of study among applicants included Medicine (MBChB), Accounting, Engineering, and Law. While the overall academic average of all entries was an impressive 81%, the top 14 finalists achieved an outstanding average of 85%.

Through a series of interviews and group activities, candidates were assessed on their critical thinking, communication skills, and ability to collaborate effectively. The Matriculant of the Year is ultimately selected for their overall balance, leadership potential, and capacity to serve as an ambassador for the UFS.

The Matriculant of the Year competition reflects the UFS’s commitment to fostering a diverse, inclusive, and equitable learning environment, aligned with the university’s values of social justice and sustainability. “By aligning this competition with Vision 130, we reaffirm the UFS’s dedication to transforming lives, creating opportunities, and shaping the next generation of leaders who will drive societal and economic progress,’’ adds Mbadi. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept